SOA Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
SOA Wealth Advisors's IBB Position: Q2 2026 in Review
SOA Wealth Advisors reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q2 2026, selling an estimated $15.6K and leaving 363 shares worth $69K. The position accounts for 0.01% of the portfolio, ranked #333.
SOA Wealth Advisors first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $175K in Q3 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- SOA Wealth Advisors held 363 shares of iShares Biotechnology ETF worth $69K as of Q2 2026.
- SOA Wealth Advisors sold 91 iShares Biotechnology ETF shares in Q2 2026, an estimated $15.6K.
- iShares Biotechnology ETF made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #333 holding.
- SOA Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's iShares Biotechnology ETF position peaked at $175K in Q3 2021.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.